New York, NY -- (SBWIRE) -- 01/27/2014 -- King Penny Stocks is an elite financial community for investors and traders alike who are looking to potentially gain financial freedom through the markets on undervalued companies and “in-play” momentum penny stocks. Today We bring special trend analysis of following stocks: WidePoint Corporation (NYSEMKT:WYY), Neuralstem, Inc. (NYSEMKT:CUR), Cleveland BioLabs, Inc. (NASDAQ:CBLI), Oxygen Biotherapeutics, Inc. (NASDAQ:OXBT)
PLUS you’ll get KingPennyStock’s Pro Trading Rules Mini E-book absolutely FREE! Claim Your Copy
WidePoint Corporation (NYSEMKT:WYY) opened its shares at the price of $1.56 for the day. Its closing price was $1.45 after losing -8.81% for the day. The company traded with the total volume of 2.28 million shares, while its average trading volume remained 1.71 million shares. The beta of WYY stands at 0.85. WidePoint Corporation provides technology-based products and solutions to government sector and commercial markets primarily in the United States. It operates in three segments: Communications Management, Cybersecurity Solutions, and Consulting Services and Products.
Has WYY Found The Bottom and Ready To Move Up? Find Out Here
Neuralstem, Inc. (NYSEMKT:CUR) percentage change plunged -8.16% to close at $3.04 with the total traded volume of 2.01 million shares, and average volume of 1.07 million. The 52 week range of the stock remained $1.00 - $3.75, while its day lowest price was $2.98 and it hit its day highest price at $3.25. Neuralstem, Inc., a biopharmaceutical company, focuses on the development and commercialization of treatments for central nervous system disease based on human neural stem cells and the use of small molecule compounds.
Has CUR Found The Bottom And Ready To Gain Momentum? Find Out Here
Cleveland BioLabs, Inc. (NASDAQ:CBLI) started its trading session with the price of $0.75 and closed at $0.690 by scoring -8.01%. CBLI’s stocks traded with total volume of 2.36 million shares, while the average trading volume remained 512,172.00 shares. The beta of CBLI stands at 1.65. Day range of the stock was $0.68 -$0.75. Cleveland BioLabs, Inc., a clinical-stage biotechnology company, engages in the research, development, and commercialization of products that have the potential to treat cancer, reduce death from total body irradiation, and counteract the genotoxic effects of radio- and chemotherapies for oncology patients.
Why Should Investors Buy CBLI After the Recent Fall? Just Go Here and Find Out
Oxygen Biotherapeutics, Inc. (NASDAQ:OXBT) ended its day with the loss of -7.90% and closed at the price of $6.41 after opening at $6.86. Stock traded during its last trading session with the total volume of 1.01 million shares, as compared to its average volume of 1.81 million shares. Oxygen Biotherapeutics, Inc., a development stage company, engages in developing biotechnology products that deliver oxygen to target tissues in the body primarily in the United States. It develops Oxycyte, a systemic perfluorocarbon based oil in water emulsion oxygen carrier for use in situations of acute ischemia; and is in Phase II-b clinical trial for the treatment of traumatic brain injury.
Will OXBT Get Buyers Even After The Recent Rally? Find Out Here
About King Penny Stocks
King Penny Stocks provides up to the minute dissemination of news while reporting on stocks that are actively traded in the small cap arena whether trading on the Nasdaq small caps, AMEX or the OTC markets. Since performance is key in our industry, it’s no wonder why our ground breaking alerts on active stocks have brought us to the forefront of this industry. Our due diligence on trend analysis has caught the attention of the very best chart technicians in the business.
King Penny Stocks is an elite financial community for investors and traders alike who are looking to potentially gain financial freedom through the markets on undervalued companies and “in-play” momentum penny stocks. Get detailed breakdowns of major trends impacting the markets.
Our newsletter, Press Release and website have been prepared for informational purposes only and are not intended to be used as a complete source of information on any particular company.
An individual should never invest in the securities of any of the companies profiled based solely on information contained in our report. Individuals should assume that all information contained in the report about profiled companies is not trustworthy unless verified by their own independent research. This report/release/advertisement is a commercial advertisement and is for general information purposes only. We are engaged in the business of marketing and advertising companies for monetary compensation.
Read our Full Disclaimer at: http://kingpennystocks.com/disclaimer/
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)